|
Volumn 33, Issue 1-2, 2001, Pages 530-531
|
FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHEMOKINE;
CYCLOSPORIN A;
FINGOLIMOD;
RAPAMYCIN DERIVATIVE;
TACROLIMUS;
ALLOGRAFT;
ANIMAL CELL;
ANIMAL EXPERIMENT;
B LYMPHOCYTE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
GRAFT REJECTION;
HUMAN;
HUMAN CELL;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE FUNCTION;
LYMPHOCYTE MIGRATION;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE;
B-LYMPHOCYTES;
CELL MOVEMENT;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
PROPYLENE GLYCOLS;
SPHINGOSINE;
T-LYMPHOCYTES;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0035076949
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)02126-6 Document Type: Article |
Times cited : (94)
|
References (12)
|